Objective: To compare the cost-effectiveness of 2 possible screening strategies for gestational diabetes mellitus (GDM) from the perspective of the New Zealand health system, developed as part of a gestational diabetes guideline. Design: A decision analytic model was built comparing 2-step screening (glycated haemoglobin (HbA1c) test at first booking and a 2 h 75 g oral glucose tolerance test (OGTT) as a single test at 24–28 weeks) with 3-step screening (HbA1c test at first booking and a 1 h glucose challenge test (GCT) followed by a 2 h 75 g OGTT when indicated from 24–28 weeks) using a 9-month time horizon. Setting: A hypothetical cohort of 62 000 pregnant women in New Zealand. Methods: Probabilities, costs and benefits were derived from ...
Background: Screening for gestational diabetes has long been a controversial topic. A previous Healt...
OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances ear...
Objectives To compare the cost-effectiveness (CE) of the National Institute for Health and Care Exce...
Objective: To compare the cost-effectiveness of 2 possible screening strategies for gestational diab...
Aims/hypothesis: the cost-effectiveness of eight strategies for screening for gestational diabetes (...
Objective: Early diagnosis of gestational diabetes mellitus (GDM) is important for both maternal and...
Introduction: Australia, but not New Zealand (NZ), has adopted the International Association of Diab...
Background: The risks associated with gestational diabetes mellitus (GDM) are well recognized, and t...
OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances ear...
Background: Gestational diabetes mellitus (GDM) is associated with a higher risk of important advers...
© 2017 Dr. Thomas James CadeBackground: The development of diabetes mellitus during pregnancy, refer...
Aims/hypothesis The aim of the study was to assess the cost-effectiveness of screening for gestation...
Background The risks associated with gestational diabetes mellitus (GDM) are well recognized, and th...
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendation
Globally, there is an alarming increase in the incidence of Type II diabetes mellitus (T2DM). It is...
Background: Screening for gestational diabetes has long been a controversial topic. A previous Healt...
OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances ear...
Objectives To compare the cost-effectiveness (CE) of the National Institute for Health and Care Exce...
Objective: To compare the cost-effectiveness of 2 possible screening strategies for gestational diab...
Aims/hypothesis: the cost-effectiveness of eight strategies for screening for gestational diabetes (...
Objective: Early diagnosis of gestational diabetes mellitus (GDM) is important for both maternal and...
Introduction: Australia, but not New Zealand (NZ), has adopted the International Association of Diab...
Background: The risks associated with gestational diabetes mellitus (GDM) are well recognized, and t...
OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances ear...
Background: Gestational diabetes mellitus (GDM) is associated with a higher risk of important advers...
© 2017 Dr. Thomas James CadeBackground: The development of diabetes mellitus during pregnancy, refer...
Aims/hypothesis The aim of the study was to assess the cost-effectiveness of screening for gestation...
Background The risks associated with gestational diabetes mellitus (GDM) are well recognized, and th...
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendation
Globally, there is an alarming increase in the incidence of Type II diabetes mellitus (T2DM). It is...
Background: Screening for gestational diabetes has long been a controversial topic. A previous Healt...
OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances ear...
Objectives To compare the cost-effectiveness (CE) of the National Institute for Health and Care Exce...